Cytokines and Interleukins in Inflammation

Cytokines are small secreted signalling proteins through which immune and tissue cells communicate, and the interleukins are a large subset of them. In inflammation, cytokines such as interleukin-1, interleukin-6, and tumour necrosis factor initiate and coordinate the response, including the hepatic acute phase reaction, and several are themselves measured as biomarkers and targeted by therapies.

Definition

Cytokines are secreted polypeptide mediators that regulate immune and inflammatory responses by binding specific cell-surface receptors; interleukins are a named subset of cytokines, and the pro-inflammatory members orchestrate the acute phase response and broader inflammation.

Scope

This entry orients the reader to the cytokine and interleukin signals that drive inflammation: their general roles, the pro- and anti-inflammatory balance, the central place of interleukin-6 in the acute phase response, and their measurement as analytes. It is a reference description and does not provide diagnostic thresholds or treatment recommendations.

Core questions

• How do cytokines initiate and coordinate the inflammatory response?
• Why is interleukin-6 central to the hepatic acute phase response?
• What distinguishes pro-inflammatory from anti-inflammatory cytokines?
• How and when are cytokines measured as biomarkers?

Key concepts

• Cytokine signalling through receptors
• Interleukin-1, interleukin-6, and tumour necrosis factor
• Interleukin-6 as driver of the acute phase response
• Pro-inflammatory versus anti-inflammatory balance
• Pleiotropy and redundancy
• Cytokine storm (hypercytokinaemia)
• Cytokines as therapeutic targets

Mechanisms

On encountering injury or microbial products, innate immune cells release early pro-inflammatory cytokines, principally interleukin-1, tumour necrosis factor, and interleukin-6. These act locally and systemically: interleukin-6 is the principal signal driving hepatocytes to produce positive acute-phase proteins such as CRP, while interleukin-1 and tumour necrosis factor amplify the response and mediate features such as fever. Anti-inflammatory cytokines and soluble receptor antagonists oppose these effects, so the net inflammatory state reflects a balance. Cytokines are pleiotropic and partly redundant, and an uncontrolled surge — sometimes called a cytokine storm — can itself cause tissue injury.

Clinical relevance

Cytokines underlie the biology measured by downstream markers such as CRP and procalcitonin, and several are themselves measured as analytes or targeted by biologic therapies in inflammatory disease. This entry describes their role as mediators and biomarkers at a reference level; it does not provide assay thresholds, drug selection, or individualized treatment guidance.

Epidemiology

Cytokine dysregulation is a feature of conditions ranging from sepsis to chronic inflammatory and autoimmune diseases, and interest in cytokine measurement grew further with attention to severe inflammatory responses in infection. Cytokine-directed biologics are widely used in immune-mediated diseases.

Evidence & guidelines

The role of cytokines in the acute phase response and inflammation is set out in broad reviews (Gabay & Kushner, 1999; Mantovani et al., 2019), with disease-specific accounts in rheumatoid arthritis (McInnes & Schett, 2011) and severe hyperinflammation (Tisoncik et al., 2012). This entry summarizes that literature at a reference level rather than as guideline direction.

History

The term interleukin was introduced in the late 1970s to bring order to the growing list of leukocyte-derived signalling factors. Subsequent decades defined interleukin-1, tumour necrosis factor, and interleukin-6 as central inflammatory mediators and clarified interleukin-6's role in the acute phase response; the resulting understanding underpinned the development of cytokine-targeted biologic therapies and the modern concept of the cytokine storm.

Debates

What defines a clinically meaningful 'cytokine storm'?

The concept of hypercytokinaemia driving organ injury is widely used, but its precise definition, thresholds, and the boundary between protective and pathological cytokine responses remain debated.

Key figures

• Charles Dinarello
• Alberto Mantovani
• Iain McInnes
• Georg Schett
• Tadamitsu Kishimoto

Seminal works

• gabay-kushner-1999
• mantovani-2019

Frequently asked questions

What is the difference between a cytokine and an interleukin?

Interleukins are a named subset of cytokines; all interleukins are cytokines, but cytokines also include other families such as tumour necrosis factor, interferons, and chemokines.

Why is interleukin-6 important for the acute phase response?

Interleukin-6 is the principal signal that instructs the liver to increase production of positive acute-phase proteins such as CRP, which links cytokine release to the measurable rise in inflammatory markers.